Phibro Animal Health Brand Guidelines: Philipp Brothers Chemicals, Sligo & a Zoetis Portfolio

A 1946 chemicals company that became an animal health group.

Phibro Animal Health began under another name. Its own timeline and English Wikipedia both say the company was formed in 1946 as Philipp Brothers Chemicals, Inc., and the Irish Times, reporting in July 2018, gave the same founding year and described Phibro as headquartered in Teaneck, New Jersey.

Animal nutrition appears early in the record. The company’s history page lists the purchase of Koffolk, an Israeli animal nutrition business, in 1974, and the establishment in 1980 of a US animal nutrition business, Prince Agri Products. A larger step came in 2000, when it acquired the global medicated feed additive business of Pfizer, a purchase English Wikipedia also records.

The name followed the business. In 2003, the company says, Philipp Brothers Chemicals was renamed Phibro Animal Health Corporation. In 2009 it bought the Baltzell US mineral nutrition business and ABIC Laboratories, an Israel-based vaccine maker, according to both the company and English Wikipedia. In 2014 Phibro completed an initial public offering; English Wikipedia says its shares were listed on the Nasdaq and that the company is incorporated in Delaware.

The acquisitions that followed, as the company lists them, filled out the range: the Animate and OmniGen-AF nutritional specialty products in 2011 and 2012, the yeast business behind Cellerate Yeast Solutions in 2015, MVP Laboratories’ animal vaccines and adjuvants in 2016, the Argentine animal health and nutrition firm Biotay in 2017, KoVax aquaculture vaccine technology in 2018, Osprey Biotechnics in 2019 and, in 2021, the remaining shares of Target Point-Technologies, an Israeli start-up that formed the basis of its automated vaccination management division.

Feed additives, minerals and vaccines.

English Wikipedia describes Phibro as an animal health and mineral nutrition company whose products include antibacterials, anticoccidials, anthelmintics, animal nutrition and vaccines for livestock, organised in three segments: Animal Health, Mineral Nutrition and Performance Materials. The Irish Times in 2018 summed up its customers as poultry, pig, cattle, dairy and aquaculture producers around the world.

Vaccines became a growing part of that mix. In July 2018 the Irish Times reported that Phibro would establish a biotech facility producing animal vaccines at the IDA Business Park in Sligo, in the north-west of Ireland, creating up to 150 jobs over five years. It was to be the company’s first manufacturing plant in Europe, starting with vaccines for poultry diseases for sale worldwide, with a hope of extending production later to livestock and aquaculture. English Wikipedia records the Sligo plant as established in 2018. Jack Bendheim, then Phibro’s chairman, president and chief executive, told the newspaper that the creation of Phibro Ireland marked “an important milestone” in the company’s development in the animal health biological market, and pointed to the experienced workforce available in the Sligo area and the strong support of IDA Ireland.

On its poultry pages the company says it markets more than 25 poultry vaccines internationally, and describes TAbic, a technology it says it has patented, which delivers vaccine antigens in effervescent tablets in place of the glass bottles traditionally used.

Pets came late. Phibro says Rejensa, launched in 2019, was its first companion animal product: joint care chews for dogs. Its companion animal pages now also list Restoris, a dental gel for dogs applied by syringe. Its website also lists mineral nutrition, plant nutrition and products for ethanol producers alongside the animal ranges.

How animal health companies present themselves.

Animal health companies speak to several audiences at once: veterinarians in clinics, farmers and producers, and the owners of dogs and cats. Their imagery tends to follow those audiences. A vet examining a dog or a cat on a consulting-room table is one of the most familiar scenes, alongside cattle in a barn, pigs in a pen and flocks of poultry, often shown with the people who look after them.

The products themselves are less photogenic, so the same few objects recur: vaccine vials, syringes, blister packs of tablets, spot-on pipettes and collars, along with laboratory benches, protective clothing and production lines. Many companies in the sector make both medicines for pets and vaccines for livestock, and their websites usually split the range by species rather than by product.

The sector also meets its customers in person. Trade fairs and congresses such as the VMX veterinary conference in Orlando and the World Veterinary Congress are where companies launch products, run booths and sponsor talks, and their stands carry much of the same photography of animals, clinics and farms.

Many of these companies also present themselves through the idea of One Health, which links the health of people, animals and the environment, and through the language of independence, family control or shared ownership where it applies. Ceva, for example, uses the slogan “Together, beyond animal health,” while Virbac points to the family that still controls it. This guide sets out what can be checked about each company: who founded it, who owns it and where it works.

Teaneck, Sligo and a Zoetis portfolio.

The largest recent change came through a purchase from Zoetis. Announced on 28 April 2024 and completed later that year, the deal transferred Zoetis’s medicated feed additive product portfolio and certain water-soluble products to Phibro. The company’s announcement, published by The Cattle Site on 12 November 2024, said the portfolio covered more than 37 product lines sold in about 80 countries, six manufacturing sites in the United States, Italy and China, and more than 300 employees. Jack C. Bendheim, then chairman, president and chief executive, said the products complemented Phibro’s vaccines, nutritional specialties and mineral nutrition.

Leadership has since changed. The trade magazine porciNews reported that from 1 July 2026 Dani Bendheim, with the company since 1997 and its executive vice president for corporate strategy, would become president and chief executive, while Jack Bendheim moved to executive chairman and remained chairman of the board. The company’s executive team page now lists Daniel M. Bendheim as president and chief executive.

The company’s website and investor pages sit at pahc.com, matching its Nasdaq ticker, PAHC. The similar address phibro.com belongs to Phibro LLC, a separate commodities business. On its own site Phibro Animal Health describes a range for livestock, aquaculture species and companion animals.

For a design guide, Phibro Animal Health shows how a company can carry a shortened version of an old chemicals name into a business built on feed additives, minerals and vaccines. Compare Zoetis, whose feed additive portfolio it bought, and Elanco, another animal-health company. For this guide we use a deep green, a wheat gold, a pale oat and an ink with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Phibro Animal Health’s identity on hand — save it to a board in the Made Good inspiration library.